Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Not applicableStudy completedNCT00737230What this trial is testingCare of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the PelvisWho this might be right forCancer Royal Marsden NHS Foundation Trust 250
Testing effectiveness (Phase 2)Study completedNCT00140400What this trial is testingPrime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate CancerWho this might be right forProstate Cancer Cell Genesys 50
Large-scale testing (Phase 3)Study completedNCT01810770What this trial is testingRadium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone MetastasisWho this might be right forProstatic Neoplasms Bayer 243
Testing effectiveness (Phase 2)UnknownNCT00122005What this trial is testingGVAX in Advanced Prostate Cancer Patients Made LymphopenicWho this might be right forProstate Cancer Providence Health & Services 18
Testing effectiveness (Phase 2)Study completedNCT01120470What this trial is testingOGX-427 in Castration Resistant Prostate Cancer PatientsWho this might be right forCastration Resistant Prostate Cancer British Columbia Cancer Agency 74
Not applicableStudy completedNCT00656305What this trial is testingExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of PainWho this might be right forBone MetastasesMultiple Myeloma InSightec 147
Not applicableNo Longer AvailableNCT01516762What this trial is testingRadium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesWho this might be right forProstatic Neoplasms Bayer
Large-scale testing (Phase 3)Study completedNCT00841113What this trial is testingAbarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate CancerWho this might be right forProstate Cancer Speciality European Pharma Limited 177
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705074What this trial is testingFAPI PET Imaging - An Exploratory StudyWho this might be right forThyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract Tumor+14 more Martin Huellner 770
Testing effectiveness (Phase 2)Study completedNCT00667862What this trial is testingEfficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate CancerWho this might be right forProstate Cancer Novartis Pharmaceuticals 35
Early research (Phase 1)Not Yet RecruitingNCT06099990What this trial is testingDalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)Who this might be right forHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Jiangsu HengRui Medicine Co., Ltd. 660
Not applicableEnded earlyNCT03465579What this trial is testingMp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.Who this might be right for68Ga-PSMA PET/CT Guided Prostate BiopsyMp-3TMRI Guided Prostate BiopsyProstate Cancer+2 more Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 261
Testing effectiveness (Phase 2)Study completedNCT02141490What this trial is testingStudy of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney CancersWho this might be right forProstate CancerBladder CancerKidney Cancer National Cancer Institute (NCI) 43
Not applicableStudy completedNCT01339780What this trial is testingImaging of Prostate and Breast Cancer Bone Metastases Using Magnetic Resonance Imaging and Nuclear Medicine TechniquesWho this might be right forBone Metastases Turku University Hospital 53
Testing effectiveness (Phase 2)Looking for participantsNCT07262619What this trial is testingEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsWho this might be right forAdvanced Solid TumorsMSI-H or dMMR Advanced Solid TumorsMSI-H/dMMR Gastric Cancer+4 more Eikon Therapeutics 160
Not applicableStudy completedNCT03604211What this trial is testingSBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution ExperienceWho this might be right forProstate Cancer RecurrentProstate CancerLymph Node Metastases Kantonsspital Graubünden 25
Not applicableStudy completedNCT01501630What this trial is testingRole of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate CancerWho this might be right forProstate Cancer Assistance Publique - Hôpitaux de Paris 112
Early research (Phase 1)Study completedNCT00005634What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03796767What this trial is testingSalvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate CancerWho this might be right forRecurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+3 more University of Utah 20